De Carlo, E., Del Savio, M. C., Polesel, J., Da Ros, V., Berto, E., Santarossa, S., . . . Bearz, A. (2018). Outcomes of ALK positive lung cancer patients treated with crizotinib or second-generation ALK inhibitor: A monoinstitutional experience. Oncotarget.
Citação norma ChicagoDe Carlo, Elisa, Maria Chiara Del Savio, Jerry Polesel, Valentina Da Ros, Eleonora Berto, Sandra Santarossa, Emanuela Chimienti, Lucia Fratino, and Alessandra Bearz. "Outcomes of ALK Positive Lung Cancer Patients Treated With Crizotinib or Second-generation ALK Inhibitor: A Monoinstitutional Experience." Oncotarget 2018.
Citação norma MLADe Carlo, Elisa, et al. "Outcomes of ALK Positive Lung Cancer Patients Treated With Crizotinib or Second-generation ALK Inhibitor: A Monoinstitutional Experience." Oncotarget 2018.